Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 8 (RN7SKP8) is a genomic sequence similar to the functional RN7SK gene, which codes for 7SK small nuclear RNA, a non-coding RNA involved in regulating transcription elongation by interacting with positive transcription elongation factor b (P-TEFb) and contributing to the control of gene expression[3][4]. Unlike RN7SK, RN7SKP8 is classified as a pseudogene, meaning it is a non-functional copy resulting from gene duplication or retrotransposition and does not produce a functional lncRNA or protein[4]. There is no specific evidence in the literature that RN7SKP8 itself plays a significant regulatory or therapeutic role. Most scientific knowledge and drug development focus on functional lncRNAs like RN7SK, which have roles in transcriptional regulation and immune cell biology, but not on their pseudogenes or RN7SKP8 specifically[1][2][3][4]. RN7SKP8 should not be considered a canonical molecular target for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 8 (RN7SKP8).